WEKO3
アイテム
{"_buckets": {"deposit": "f4cc5a3c-4aa6-44f5-a776-2bab5d66f1c4"}, "_deposit": {"created_by": 2, "id": "20113", "owners": [2], "pid": {"revision_id": 0, "type": "depid", "value": "20113"}, "status": "published"}, "_oai": {"id": "oai:nagasaki-u.repo.nii.ac.jp:00020113", "sets": ["1390"]}, "author_link": ["84767", "84766", "84768"], "item_3_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "1996-12", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "3-4", "bibliographicPageEnd": "14", "bibliographicPageStart": "8", "bibliographicVolumeNumber": "41", "bibliographic_titles": [{"bibliographic_title": "Acta medica Nagasakiensia"}]}]}, "item_3_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "The psychopharmacological management of schizophrenia consists primarily of neuroleptics. These drugs have successfully changed the scenario of psychiatry since the 1950s. They have mainly been used for controlling positive symptoms in schizophrenia, but on closer look it is evident that positive and negative symptoms both respond to neuroleptics in the acute and chronic stages of schizophrenia separate reports are cited for acute and chronic stages with an aim to quantitate the response. The early as well as recent studies support these obervations with few exceptions. However, greater responsivity has been observed in the acute stages of schizophrenia.", "subitem_description_type": "Abstract"}]}, "item_3_description_64": {"attribute_name": "引用", "attribute_value_mlt": [{"subitem_description": "Acta medica Nagasakiensia. 1996, 41(3-4), p.8-14", "subitem_description_type": "Other"}]}, "item_3_source_id_10": {"attribute_name": "書誌レコードID", "attribute_value_mlt": [{"subitem_source_identifier": "AA00508430", "subitem_source_identifier_type": "NCID"}]}, "item_3_source_id_7": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "00016055", "subitem_source_identifier_type": "ISSN"}]}, "item_3_text_62": {"attribute_name": "sortkey", "attribute_value_mlt": [{"subitem_text_value": "P00008-P00014"}]}, "item_3_version_type_16": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Srivastava, Jagdishwars"}], "nameIdentifiers": [{"nameIdentifier": "84766", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Okazaki, Yuji"}], "nameIdentifiers": [{"nameIdentifier": "84767", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nakane, Yoshibumi"}], "nameIdentifiers": [{"nameIdentifier": "84768", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2020-12-23"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "acta41_03_02_t.pdf", "filesize": [{"value": "916.7 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 916700.0, "url": {"label": "acta41_03_02_t.pdf", "url": "https://nagasaki-u.repo.nii.ac.jp/record/20113/files/acta41_03_02_t.pdf"}, "version_id": "5ead814f-5a79-4c75-a760-0837efe50731"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "negative symptoms", "subitem_subject_scheme": "Other"}, {"subitem_subject": "neuroleptic drugs", "subitem_subject_scheme": "Other"}, {"subitem_subject": "schizophrenia", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Responsivity of Negative Symptoms to Typical Neuroleptic Drugsin Schizophrenia", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Responsivity of Negative Symptoms to Typical Neuroleptic Drugsin Schizophrenia"}]}, "item_type_id": "3", "owner": "2", "path": ["1390"], "permalink_uri": "http://hdl.handle.net/10069/16058", "pubdate": {"attribute_name": "公開日", "attribute_value": "2008-03-13"}, "publish_date": "2008-03-13", "publish_status": "0", "recid": "20113", "relation": {}, "relation_version_is_last": true, "title": ["Responsivity of Negative Symptoms to Typical Neuroleptic Drugsin Schizophrenia"], "weko_shared_id": -1}
Responsivity of Negative Symptoms to Typical Neuroleptic Drugsin Schizophrenia
http://hdl.handle.net/10069/16058
http://hdl.handle.net/10069/160585a49aab0-d8d8-465e-90aa-4e9744e8aab0
名前 / ファイル | ライセンス | アクション |
---|---|---|
acta41_03_02_t.pdf (916.7 kB)
|
|
Item type | 紀要論文 / Departmental Bulletin Paper(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2008-03-13 | |||||
タイトル | ||||||
タイトル | Responsivity of Negative Symptoms to Typical Neuroleptic Drugsin Schizophrenia | |||||
言語 | ||||||
言語 | eng | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | negative symptoms | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | neuroleptic drugs | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | schizophrenia | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | departmental bulletin paper | |||||
著者 |
Srivastava, Jagdishwars
× Srivastava, Jagdishwars× Okazaki, Yuji× Nakane, Yoshibumi |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | The psychopharmacological management of schizophrenia consists primarily of neuroleptics. These drugs have successfully changed the scenario of psychiatry since the 1950s. They have mainly been used for controlling positive symptoms in schizophrenia, but on closer look it is evident that positive and negative symptoms both respond to neuroleptics in the acute and chronic stages of schizophrenia separate reports are cited for acute and chronic stages with an aim to quantitate the response. The early as well as recent studies support these obervations with few exceptions. However, greater responsivity has been observed in the acute stages of schizophrenia. | |||||
書誌情報 |
Acta medica Nagasakiensia 巻 41, 号 3-4, p. 8-14, 発行日 1996-12 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 00016055 | |||||
書誌レコードID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AA00508430 | |||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
sortkey | ||||||
P00008-P00014 | ||||||
引用 | ||||||
内容記述タイプ | Other | |||||
内容記述 | Acta medica Nagasakiensia. 1996, 41(3-4), p.8-14 |